Advanced Medical Solutions Group plc (LON:AMS – Get Free Report) shares passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 213.35 and traded as high as GBX 219.25. Advanced Medical Solutions Group shares last traded at GBX 215.50, with a volume of 555,265 shares traded.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reiterated a “buy” rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research report on Thursday, January 15th. Three research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of GBX 273.67.
Get Our Latest Research Report on Advanced Medical Solutions Group
Advanced Medical Solutions Group Price Performance
Advanced Medical Solutions Group Company Profile
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.
Featured Articles
- Five stocks we like better than Advanced Medical Solutions Group
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for Advanced Medical Solutions Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advanced Medical Solutions Group and related companies with MarketBeat.com's FREE daily email newsletter.
